Scientists identify two genes involved in the cerebral effects of boys and girls with obsessive-compulsive symptoms

by Hospital Universitari de Bellvitge

3 years ago
Mental Health, Neuroscience, Obsessive Compulsive Disorder, OCD

Obsessive Compulsive Disorder (OCD) is characterized by the appearance of intrusive thoughts or impulses that end up leading to repetitive behaviors. Between 1 and 3% of the population suffer from thi...

CAC, IDIBELL, and Hospital de Bellvitge offer scholar course to prevent addictions to video games and gambling

by Hospital Universitari de Bellvitge

3 years ago
young people, Addictions, video games, Neuroscience, Outreach and education, Mental Healt

In 15 years, it has multiplied by five (from 2% to 9.5%) the number of young people between 16 and 21 years old treated in the Pathological Gambling and Other Addictions Unit of the Bellvitge Hospital...

New tool to assess epilepsy cases that need surgery

by Hospital Universitari de Bellvitge

3 years ago
Cognition and Brain Plasticity, Neuroscience, epilepsy

The Cognition and Brain Plasticity group at IDIBELL, the Bellvitge University Hospital and the University of Barcelona have found an indicator that could help predict the evolution of patients with dr...

Identification of a new mitochondrial syndrome characterized by multisystemic involvement

by Hospital Universitari de Bellvitge

3 years ago
Neurometabolic diseases, Neuroscience, mitochondrial syndrome

An international multicenter consortium involving the Bellvitge Institute for Biomedical Research (IDIBELL) has identified a new mitochondrial syndrome characterized by multisystemic involvement with ...

Two new genetic variants associated with suicide attempts help disentangle related risk factors

by Hospital Universitari de Bellvitge

3 years ago
Mental Health, Neuroscience, Psychiatry, Suicide

A genetic study including more than half a million patients by the International Suicide Genetics Consortium, with the participation of IDIBELL and Bellvitge Hospital, has identified two new variants ...

Vocal music boosts the recovery of language functions after stroke

by Hospital Universitari de Bellvitge

3 years ago
Neuroscience, brain health, stroke, Music

Listening to vocal music is a simple and cost-efficient way of promoting recovery and brain health after a stroke.

Exercise prevents neuronal damage caused by lung cancer treatment

by Hospital Universitari de Bellvitge

3 years ago
Neuro-Oncology, Neuroscience, Cancer, lung cancer, Exercise

A study of IDIBELL, ICO, and Bellvitge University Hospital shows that exercise not only prevents the loss of neuronal tissue caused by chemotherapy and radiotherapy. Also, patients who follow sports g...

IDIBELL researchers identify a brain region that predicts the evolution of apathy in Huntington’s patients

by Hospital Universitari de Bellvitge

3 years ago
Cognition, Brain Plasticity, Neuroscience, Huntington

The atrophy of a specific region of the cerebral cortex is related to the appearance of apathy in Huntington’s patients, a neurodegenerative disease that affects motor and cognitive function. This i...

The brain can teach artificial intelligence a lesson or two: the neural mechanism of autonomous learning uncovered by researchers at IBEC

by IBEC - Institut de Bioenginyeria de Catalunya

3 years ago
artificial intelligence, neuroscience

Possible new biomarker for Parkinson’s disease

by Hospital Universitari de Bellvitge

4 years ago
Neuroscience, Neuropharmacology, biomarker, Parkinson

The study, published in the journal Translational Neurodegeneration and led by Dr. Francisco Ciruela, shows that only patients with Parkinson’s disease patients, and not with other neurodegenerative...

The ‘Journal of Neuroeducation’, the first neuroeducation research journal in Spain

by Universitat de Barcelona

5 years ago
neuroscience, education, research, Neuroeducation

Building bridges between the science and education communities to contribute and improve the current didactic experiences is the goal of the Journal of Neuroeducation (JONED), a new online free-access...

Minoryx Therapeutics receives US FDA fast-track designation for leriglitazone in the treatment of X-ALD

by Minoryx Therapeutics

5 years ago
Central Nervous System, drug, Friedreich’s Ataxia, neuroscience

Leriglitazone (MIN-102), a novel, brain penetrant, orally bioavailable and selective PPARγ agonist, is currently in late-stage development for treatment of severe orphan CNS disorders, including X-AL...